PAR

5.00%

19.0¢ paradigm biopharmaceuticals limited..

Just wondering if anyone has contacted the company to find out...

First 618 Last

Share
Profile

Follow
goldmad

1,079 Posts.

269

11/01/24

12:26

Post #: 71830156
Share

Originally posted by Dungiven: ↑

Thanks Denial. So, from $23 per 1% TAM to $16 per 1% TAM due to the last CR alone? This hammers home the opportunity cost of their inability to manage capital requirements responsibly. They twiddled their thumbs at the SP highs, and then panic-raised at the SP lows - because they naively expected huge SP rallies on 008 announcements. The market makers really saw them coming from miles away. Spinning lies about imminent deals and non-dilutive funding right up to days before their embarrassing capitulation to their "friends" at Bell Potter et al.

I'm nowhere near convinced by their claim that they are now funded until mid-2025. Frankly, that's likely to be just another lie. So what similar damage will another CR (this time in the 30's or 20's) do? The damage will just compound, and that $16 per 1% can, and probably will, fall dramatically again.

If they don't sign deals for major up-front money in the next 6 months, we'll find out imo.

I still can't believe they view coming through on this company necessity as a "stretch target" and feel that they should carve off more of shareholders cash in order to get the job done.

While remaining a long-term bull, I have become a short-term bear regarding PAR. I am inclined to think we will continue to pay the price for management butchering the capital management opportunities of the past, and for their self-congratulatory FIGJAM approach to all communications, business strategy, and company activity.

Paul and Amos's performances at the AGM showed no change of gear, no uplift in approach, despite the absolutely stinging chastisement of their performance by the market that is baked into today's share price. They are failing at their quest to "maximise results for shareholders". Failing. Demonstrably and miserably. They can now only scramble to save what is left and it begins and ends with deals, and non-dilutive funding in the next 6 months otherwise it just gets worse and worse and worse.

Expand

Just wondering if anyone has contacted the company to find out what the delay is?

PAR Price at posting: 42.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

There are more pages in this discussion • 635 more messages in this thread...

First 618 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 19.0¢		Change -0.010(5.00%)		Mkt cap ! $66.54M

Open	High	Low	Value	Volume
20.0¢	21.0¢	19.0¢	$203.4K	1.019M

Buyers (Bids)

No.	Vol.	Price($)
14	387930	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	65468	2

View Market Depth

No.	Vol.	Price($)
13	384246	0.190
3	57000	0.185
8	194873	0.180
6	140904	0.175
7	595605	0.170

Price($)	Vol.	No.
0.205	65468	2
0.210	25992	3
0.215	30000	1
0.220	27066	4
0.225	21604	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PAR (ASX) Chart

Just wondering if anyone has contacted the company to find out...

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Just wondering if anyone has contacted the company to find out...

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News